← Evidence map

ReviewCancers2023

Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine.

Francesco Di Costanzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36672366